23andMe wants to be a drug company

• The company has 70 scientists working on those compounds, plus 2 more potential drugs that are further along in the process.
• And all of that comes on top of 23andMe's partnership with established drugmakers. It struck a $300 million deal with GlaxoSmithKline last year.

The intrigue: The overwhelming majority of efforts to create a new drug end in failure. But 23andMe is hoping its vast stores of human DNA information will give it a better shot, per Business Insider.